|
|
7F, 138, Hsin Ming Road, Neihu District
Taipei, 114 R.O.C. Taiwan
phone:886 (2) 81777072
fax:886-2-27963606
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.taigenbiotech.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Development stage pharmaceutical company |
|
| Management |
| Ming-Chu Hsu, Founder, President, CEO and Chairman of the Board; Show Chung Ho, Steering Committee Member and Director; Michael Steinmetz, Steering Committee Member and Director; Jack Lief, Steering Committee Member and Director; Steve Lee, Board of the Director and Steering Committee Member; William Robert Keller, Board of Director; Jing Lin, Chief Financial Officer, Finance & Administration; Stephen H., Senior Vice President, Global Business Development; Philip, Kuo-Lung Huang, VP Product Development & Marketing General Manager,
TaiGen Beijing office; Chi-Hsin Richard King, Vice President, Chemistry; Gene C. Hsu, Vice President , Preclinical |
| |
|
|
| |
|
| Keywords |
| Infectious Disease, infection, bacterias, Cancer, Autoimmune/Inflammation, Urology, Urology, prostate, urinary, bladder, erectile, urinary, bladder, erectile, GI, InfectiousDisease |
|
|
|
| Description |
|
They plan to become a fully integrated pharmaceutical company with discovery research, clinical development operation, and commercialize products with direct sales team in the Asia Pacific region including Taiwan, mainland China, Singapore, Malaysia, and Ascean countries |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members